Loading...

IDH1-mutated relapsed or refractory AML: current challenges and future prospects

The prognosis of patients with relapsed or refractory acute myeloid leukemia (R/R AML) is discouraging with salvage standard approaches. Mutations of isocitrate dehydrogenase 1 (IDH1(mut)), present in 7–14% of AML patients, have been discovered recently, opening the door to targeted agents aiming to...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Blood Lymphat Cancer
Main Authors: Megías-Vericat, Juan Eduardo, Ballesta-López, Octavio, Barragán, Eva, Montesinos, Pau
Format: Artigo
Sprog:Inglês
Udgivet: Dove 2019
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6663038/
https://ncbi.nlm.nih.gov/pubmed/31413655
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BLCTT.S177913
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!